Teva Pharma (TEVA) Gains on Bill Miller Mention

Teva Pharma (NYSE: TEVA) gained mid-day after famed investor Bill Miller of the Miller Value Fund called the stock his number one pick on CNBC.

Miller thinks TEVA can grow to $25-$30 per share.

Shares quickly rose 4% after he mentioned it.

You May Also Be Interested In

• Aurinia settles patent dispute with Teva over generic voclosporin
• Hunterbrook bullish on Modine Manufacturing (MOD)
• FTC files amicus brief challenging Amgen's Enbrel patent acquisition